REMAV-EIT: REcruitment MAneuvers and Mechanical Ventilation Guided by EIT in pARDS

Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (Other)
Overall Status
Recruiting
CT.gov ID
NCT06067152
Collaborator
(none)
13
1
3
24.9
0.5

Study Details

Study Description

Brief Summary

There is evidence from randomized controlled trials in adult patients with Acute Respiratory Distress Syndrome (ARDS) suggesting that delivering small tidal volumes with adequate levels of Positive End-Expiratory Pressure (PEEP) and a restrictive fluid strategy could improve outcome. However, there are data and common bedside experience that individual patients may or may not respond to interventions, such as escalation of PEEP or positional changes, and there may be a role for a more personalized ventilator strategy.

This strategy could account for the unique individual morphology of lung disease, such as the amount of atelectasis and overdistension as a percentage of total lung tissue, the exact location of atelectasis, and whether positional changes or elevation of PEEP produce lung recruitment or overdistension.

Stepwise Recruitment maneuvers (SRMs) in pARDS improve oxygenation in majority of patients. SRMs should be considered for use on an individualized basis in patients with pARDS should be considered if SpO2 decreases by ≥ 5% within 5 minutes of disconnection during suction or coughing or agitation. If a recruitment maneuver is conducted, a decremental PEEP trial must be done to determine the minimum PEEP that sustains the benefits of the recruitment maneuver.

Electrical impedance tomography (EIT), a bedside monitor to describe regional lung volume changes, displays a real-time cross-sectional image of the lung. EIT is a non-invasive, non-operator dependent, bedside, radiations-free diagnostic tool, feasible in paediatric patients and repeatable. It allows to study ventilation distribution dividing lungs in four Region Of Interest (ROI), that are layers distributed in an anteroposterior direction, and shows how ventilation is distributed in the areas concerned.

EIT measures and calculates other parameters that are related not only to the distribution of ventilation, but also to the homogeneity of ventilation and the response to certain therapeutic maneuvers, such as SRMs or PEEP-application.

Aim of this study is to provide a protocolized strategy to assess optimal recruitment and PEEP setting, tailored on the patients individual response in pARDS.

Condition or Disease Intervention/Treatment Phase
  • Device: EIT measurement
  • Device: Staircase Recruitment Maneuvers with EIT guided and decremental PEEP trial
  • Device: Setting of EIT-guided mechanical ventilation
  • Device: Reevaluation after 24 h
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
13 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
REcruitment MAneuvers and Mechanical Ventilation Guided by EIT in Pediatric Acute Respiratory Distress Syndrome (pARDS)
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Jan 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: T0= Enrollment

mechanical ventilation will be set according to the standard of care criteria

Device: EIT measurement
Evaluation of mechanical ventilation and ventilation distribution through EIT. Mechanical ventilation is set by the physician according to clinical protocolized criteria

Active Comparator: T1= guided MV at the end of SRM trial

EIT guided mechanical ventilation will be set

Device: Staircase Recruitment Maneuvers with EIT guided and decremental PEEP trial
SRMs will be performed with a standardized ventilation protocol. Patient will be sedated, paralyzed and ventilated in pressure controlled mode, FIO2 to obtain SPO2> 92%, RR 25, I:E =1:1.5. Alarm of pressure limit will be set at 35 cmH2O. The ventilator will be equipped with inspiratory and expiratory hold taste. Inspiratory and expiratory occlusion will be held for 5 seconds, data will be stored and analyzed with the ventilator own tool. Decremental PEEP trial will start if plateau pressure 30 cmH2O will be reached or end inspiratory transpulmonary pressure will exceed 28 cmH2O value. Once reached this level of plateau or transpulmonary pressure, PEEP will be reduced in three steps from 12, 10 and finally to 8 cmH2O every 20 minutes
Other Names:
  • SRMs EIT-guided and DP trial
  • Device: Setting of EIT-guided mechanical ventilation
    Mechanical ventilation is set according to EIT measurement

    Active Comparator: T2= 24 hours with EIT guided MV

    evaluation of mechanical ventilation after 24h EIT-guided ventilation

    Device: Reevaluation after 24 h
    Evaluation of mechanical ventilation and ventilation distribution through EIT after 24h of ventilation EIT-guided

    Outcome Measures

    Primary Outcome Measures

    1. Regional Ventilation Delay, RDV (pixels %), at T2 and T0 [1 day]

      RDV is an index of atelectrauma, supra-distention and in general an inhomogeneous ventilation

    Secondary Outcome Measures

    1. Differences in Tidal Impedance Distribution,TID (pixels %), at T0, T1 and T2 [1 day]

      for every breathing cycle, a so-called tidal image is generated and each pixel of represents the difference in impedance between end-inspiration and end-expiration. The median value of each tidal image is calculated for the lung area

    2. Gravity Centre, GC, differences (pixels %) at T0, T1 and T2 [1 day]

      it is the weighted mean of row sums obtained from TV image and it indicates ventral-to-dorsal shifts in ventilation distribution due to lung opening and closing

    3. Respiratory Rate at T0, T1 and T2 [1 day]

      Respiratory rate (breaths/min)

    4. FiO2 (%) at T0, T1 and T2 [1 day]

      FiO2 (%)

    5. Respiratory compliance at T0, T1 and T2 [1 day]

      Respiratory System Compliance

    6. Lung compliance at T0, T1 and T2 [1 day]

      Clung Lung compliance

    7. Chest Wall compliance at T0, T1 and T2 [1 day]

      Chest Wall compliance

    8. S/F ratio at T0, T1 and T2 [1 day]

      S/F ratio

    9. Sistolic Blood Pressure at T0, T1 and T2 [1 day]

      SBP (mmHg)

    10. Diastolic Blood Pressure at T0, T1 and T2 [1 day]

      DBP (mmHg)

    11. pH at T0, T1 and T2 [1 day]

      pH

    12. SpO2 at T0, T1 and T2 [1 day]

      SpO2 (%)

    13. PaO2 at T0, T1 and T2 [1 day]

      PaO2 (mmHg)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 5 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Intubated and mechanically ventilated children, ageing 1 months-5 years and meeting the PALICC definition for pediatric Acute Respiratory Distress Syndrome (pARDS)

    • Informed Consent signed

    Exclusion Criteria: Patients with one or more of the following characteristics:
    • Previous barotrauma (pneumothorax, pneumomediastinum or subcutaneous emphysema)

    • Signs of intracranial hypertension

    • Cyanotic congenital cardiac disease

    • Dorso-lumbar pathologies or other bone pathologies associated with restrictive lung disease (such as scoliosis, kyphosis)

    • Implantable devices not compatible with EIT (such as pace-makers and implantable cardioverter defibrillator)

    • Controindication to positioning the esophageal catheter (surgery, esophageal stenosis)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico Milano Milan Italy 20122

    Sponsors and Collaborators

    • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    Investigators

    • Principal Investigator: Giovanna Chidini, MD, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
    ClinicalTrials.gov Identifier:
    NCT06067152
    Other Study ID Numbers:
    • REMAV-EIT
    First Posted:
    Oct 4, 2023
    Last Update Posted:
    Oct 4, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 4, 2023